BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 11025599)

  • 1. Mucormycosis in hematologic malignancies: an emerging fungal infection.
    Nosari A; Oreste P; Montillo M; Carrafiello G; Draisci M; Muti G; Molteni A; Morra E
    Haematologica; 2000 Oct; 85(10):1068-71. PubMed ID: 11025599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia.
    Salonen JH
    Acta Biomed; 2006; 77 Suppl 2():28-31. PubMed ID: 16918065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes.
    Pagano L; Mele L; Fianchi L; Melillo L; Martino B; D'Antonio D; Tosti ME; Posteraro B; Sanguinetti M; Trapè G; Equitani F; Carotenuto M; Leone G
    Haematologica; 2002 May; 87(5):535-41. PubMed ID: 12010669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucormycosis-associated fungal infections in patients with haematologic malignancies.
    Kara IO; Tasova Y; Uguz A; Sahin B
    Int J Clin Pract; 2009 Jan; 63(1):134-9. PubMed ID: 17362481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
    Bethge WA; Schmalzing M; Stuhler G; Schumacher U; Kröber SM; Horger M; Einsele H; Kanz L; Hebart H
    Haematologica; 2005 Nov; 90 Suppl():ECR22. PubMed ID: 16266913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies.
    Nosari A; Anghilieri M; Carrafiello G; Guffanti C; Marbello L; Montillo M; Muti G; Ribera S; Vanzulli A; Nichelatti M; Morra E
    Haematologica; 2003 Dec; 88(12):1405-9. PubMed ID: 14687995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion.
    Nosari A; Oreste P; Cairoli R; Montillo M; Carrafiello G; Astolfi A; Muti G; Marbello L; Tedeschi A; Magliano E; Morra E
    Am J Hematol; 2001 Dec; 68(4):231-6. PubMed ID: 11754411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rhino-cerebral mucormycosis and hematological neoplasia].
    Pintado V; Valencia ME; López-Dupla JM; Lavilla P; Feliú J; Gil A
    Sangre (Barc); 1991 Apr; 36(2):141-3. PubMed ID: 1866653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mucormycosis: retrospective evaluation of 12 cases].
    Arda B; Erdem A; Sipahi OR; Işıkgöz Taşbakan M; Pullukçu H; Taşbakan MS; Ceylan N; Metin DY; Midilli R; Yamazhan T; Ulusoy S
    Mikrobiyol Bul; 2011 Jul; 45(3):504-11. PubMed ID: 21935783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of invasive mucormycosis--effectiveness of the Echinocandin FK463.
    Jacobs P; Wood L; Du Toit A; Esterhuizen K
    Hematology; 2003 Apr; 8(2):119-23. PubMed ID: 12745662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit.
    Girmenia C; Alimena G; Latagliata R; Morano SG; Celesti F; Coppola L; Spadea A; Tosti S; Mecarocci S; D'Elia GM; Tafuri A; Cimino G; Mandelli F
    Haematologica; 1999 Sep; 84(9):814-9. PubMed ID: 10477455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucormycosis in the BMT population.
    Morrison VA; McGlave PB
    Bone Marrow Transplant; 1993 May; 11(5):383-8. PubMed ID: 8504272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program.
    Pagano L; Girmenia C; Mele L; Ricci P; Tosti ME; Nosari A; Buelli M; Picardi M; Allione B; Corvatta L; D'Antonio D; Montillo M; Melillo L; Chierichini A; Cenacchi A; Tonso A; Cudillo L; Candoni A; Savignano C; Bonini A; Martino P; Del Favero A; ;
    Haematologica; 2001 Aug; 86(8):862-70. PubMed ID: 11522544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucormycosis after kidney transplantations: report of seven cases.
    Aslani J; Eizadi M; Kardavani B; Khoddami-Vishteh HR; Nemati E; Hoseini SM; Einollahi B
    Scand J Infect Dis; 2007; 39(8):703-6. PubMed ID: 17654347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
    Sungkanuparph S; Sathapatayavongs B; Kunachak S; Luxameechanporn T; Cheewaruangroj W
    J Med Assoc Thai; 2001 Apr; 84(4):593-601. PubMed ID: 11460976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia.
    Nosari A; Ravini M; Cairoli R; Cozzi P; Marbello L; Marenco P; Grillo G; Morra E
    Bone Marrow Transplant; 2007 May; 39(10):631-5. PubMed ID: 17384656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucormycosis in hematologic patients.
    Pagano L; Offidani M; Fianchi L; Nosari A; Candoni A; Picardi M; Corvatta L; D'Antonio D; Girmenia C; Martino P; Del Favero A;
    Haematologica; 2004 Feb; 89(2):207-14. PubMed ID: 15003897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous peripheral blood stem cell transplantation in a patient with previous invasive middle ear mucormycosis.
    Olalla I; Ortín M; Hermida G; Cortés MA; Richard C; Iriondo A; Mozota ML; Zubizarreta A
    Bone Marrow Transplant; 1996 Dec; 18(6):1183-4. PubMed ID: 8971393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
    Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.